Featured Research

from universities, journals, and other organizations

New syndrome caused by mutations in AHDC1

Date:
May 1, 2014
Source:
Baylor College of Medicine
Summary:
The gene underlying a newly recognized genetic syndrome that has symptoms of sleep apnea, delayed speech and hyptonia, or generalized upper body weakness, has been discovered by researchers. "Little is known about this gene and the discovery of its link to this syndrome is an important advance towards analyzing its function," said a corresponding author. "This study illustrates a remarkable confluence of advanced technical development, data sharing and detailed clinical studies."

A team of researchers led by Baylor College of Medicine have identified the gene underlying a newly recognized genetic syndrome that has symptoms of sleep apnea, delayed speech and hyptonia, or generalized upper body weakness.

The study published online today in the American Journal of Human Genetics.

The Baylor researchers first studied a patient from Australia with these symptoms who had been seen by many doctors and had multiple diagnostic tests, without any diagnosis.

Although there was no family history of the disease, the researchers performed DNA sequence analysis on the patient and her parents to determine if there was an underlying genetic cause for her symptoms.

The results showed damaging mutations had newly arisen in five genes in the patient when compared with the parents DNA sequence.

One gene was a candidate for causing the disease because similar mutations were never seen in healthy control individuals.

"This led us to ask if there were any other undiagnosed disease cases that had similar mutations in this gene," said Dr. Fan Xia, assistant professor of molecular and human genetics and in the Whole Genome Laboratory at Baylor and the first author on the report.

An examination of data from unsolved cases at Baylor's Whole Genome Laboratory revealed three such possibilities, Xia said.

The team then performed DNA sequencing on these patients and their parents.

"We found that these patients also had damaging mutations that had newly arisen in the same gene AHDC1," said Xia. "The independent occurrence of new mutations in each of these families is extremely strong evidence that this gene is the cause of this syndrome."

The mutations are in the 'AT-Hook binding DNA motif Containing' gene, AHDC1.

"Little is known about this gene and the discovery of its link to this syndrome is an important advance towards analyzing its function," said Dr. Richard Gibbs, director of the Human Genome Sequencing Center at Baylor and the corresponding author on the report.

Checking the clinical records of the four patients showed an unrealized similarity between the symptoms of each patient. The DNA discovery had therefore brought together patients from Australia, Pennsylvania and two different cities in Texas.

"This study illustrates a remarkable confluence of advanced technical development, data sharing and detailed clinical studies," said Gibbs. "We have simultaneously provided answers for the affected families and advanced an important basic research question."

The researchers noted that the frequency of this syndrome is not yet known, but extrapolating from the Baylor Whole Genome Laboratory suggests that there could be hundreds of affected individuals worldwide.


Story Source:

The above story is based on materials provided by Baylor College of Medicine. The original article was written by Glenna Picton. Note: Materials may be edited for content and length.


Journal Reference:

  1. Fan Xia et al. De Novo Truncating Mutations in AHDC1 in Individuals with Syndromic Expressive Language Delay, Hypotonia, and Sleep Apnea. American Journal of Human Genetics, May 2014 DOI: 10.1016/j.ajhg.2014.04.006

Cite This Page:

Baylor College of Medicine. "New syndrome caused by mutations in AHDC1." ScienceDaily. ScienceDaily, 1 May 2014. <www.sciencedaily.com/releases/2014/05/140501123455.htm>.
Baylor College of Medicine. (2014, May 1). New syndrome caused by mutations in AHDC1. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/05/140501123455.htm
Baylor College of Medicine. "New syndrome caused by mutations in AHDC1." ScienceDaily. www.sciencedaily.com/releases/2014/05/140501123455.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins